FREYR Battery (NYSE:FREY) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.30) by 166.67 percent. This is a 90.48 percent decrease over losses of $(0.42) per share from the same period last year.
Clearmind Medicine To Pioneer Psychedelic Clinical Trials For Alcohol Use Disorder With Ivy League Universities
Company entered a Clinical Trial Agreement with Johns Hopkins University School of Medicine and Yale University to conduct its first in-human clinical trialTel Aviv, Israel / Vancouver, Canada, Nov. 09, 2023 (GLOBE